abs343.txt	background		statin	use	is	associated	with	lower	advanced	prostate	cancer	risk	andreduced	prostate	cancer-specific	mortality		but	prior	studies	were	conductedmainly	in	white	men		we	examined	the	effect	of	statin	use	on	risk	of	prostatecancer	progression	in	a	population-based		minority-enriched	cohort	methods		we	used	data	from	prostate	cancer	cases	(45%	african	american)	diagnosedbetween	2004	and	2007	who	participated	in	the	health	care	access	and	prostatecancer	treatment	in	north	carolina	cohort	(hcap-nc)		we	abstracted	statin	use	atdiagnosis		men	reported	if	they	had	ever	been	diagnosed	with	high	cholesterol	multivariable	cox	proportional	hazards	analysis	was	used	to	examine	associationsbetween	statin	use	and	risk	of	prostate	cancer	progression	(biochemicalrecurrence	or	secondary	treatment)		overall	and	by	race		in	secondary	analysis	we	examined	the	association	between	high	cholesterol	and	risk	of	progression	overall		and	by	statin	use	results		of	669	men		244	(36%)	were	statin	users	at	diagnosis		during	3	8	yearsmedian	follow-up		138	men	experienced	prostate	cancer	progression		there	was	noassociation	between	statin	use	and	risk	of	progression		either	overall	(hr	1	03	95%ci	0	72-1	46)	or	stratified	by	race		high	cholesterol	was	inversely	associatedwith	risk	of	progression		particularly	among	statin	users	(hr	0	43		95%ci0	20-0	94		p-interaction	=	0	22)	and	in	men	with	higher	perceived	access	to	care(hr	0	57		95%ci	0	36-0	90		p-interaction	=	0	03)		study	limitations	included	arelatively	small	sample	size		short	follow-up		and	lack	of	data	regarding	postdiagnosis	statin	use	conclusions		statin	use	at	diagnosis	was	not	associated	with	prostate	cancerprogression	in	the	population-based		minority-enriched	hcap-nc		greaterhealthcare	engagement		including	actively	controlling	serum	cholesterol		may	belinked	to	better	prostate	cancer-specific	outcomes	
